Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	48	non-cytoplasmic
49	68	transmembrane
69	80	cytoplasmic
81	100	transmembrane
101	106	non-cytoplasmic
107	131	transmembrane
132	141	cytoplasmic
142	162	transmembrane
163	173	non-cytoplasmic
174	196	transmembrane
197	239	cytoplasmic
240	262	transmembrane
263	273	non-cytoplasmic
274	297	transmembrane
298	308	cytoplasmic
309	327	transmembrane
328	332	non-cytoplasmic
333	352	transmembrane
353	360	cytoplasmic
361	385	transmembrane
386	396	non-cytoplasmic
397	417	transmembrane
418	431	cytoplasmic

Input:
>Pf6N2E2_1105
MKTLPVSVLAKISWRLLPFLLLMYIMAFLDRANVGFAKQAFQADTGIGDAAFAFGAGVFF
AGYALLEVPSNLILHRVGARLWMCRIMVTWGLVSAAMVFAHNETSFYVLRFLLGVAEAGF
FPGVILYLTYWFPSAARGKAMGFFYFGAPLAFIFGSPLSGLLLELDGFAGVHGWQWLFAV
EGLMASAVGIWAYWYLDNRPADAKWLTVEERRQVQSLLDAEDQHKQSHGRSLLSVLCQPS
VLYLCLIYLLIQASVYGVVFYLPTQVGGLLGSKVGLMVGLVTAIPWICALCAAYLIPGYS
DRTGQRRRTAALTLLMAAAGIACSVSVSSPLLGIIALCFAASGFIAVQPVFWTFPSSYLA
GSAAAAGIALINSFGALGGFIAPVLKNWAEGAFHSPAAGLYLLSVTTVIAALLVLGIHSP
GQRASKTPATV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server